Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Ross Camidge Stories

2013-04-17 15:16:42

Study details side effect rate, mechanism and treatment A previous study by the University of Colorado Cancer Center reported the common side effect of low testosterone in men treated with the recently approved lung cancer agent, crizotinib. A new study published this week in the journal Cancer confirms this finding in a multi-national sample, details the mechanism of reduced testosterone, and provides promising preliminary evidence that widely available hormone replacement therapies can...

2005-06-14 18:45:14

Health professionals led by a cancer specialist from the University of Edinburgh have put forward the case for finding new and fairer ways to assess the value of treatments for patients who will eventually die from their condition. Writing in the current edition of the British Medical Journal (10 June, 2005) the experts argue that this issue should be explored because of its impact on national decisions about which new treatments are funded. Lead author of the BMJ article, Dr Ross Camidge,...